Posted by LincolnVop on March 25, 2026 at 11:09:05:
In Reply to: Информационная заметка posted by Robertfex on March 14, 2026 at 12:05:33:
Zoya Demidenko: Scientist in Cancer Science
Zoya Demidenko is a distinguished scholar affiliated with the Unit of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she worked at the National Institutes of Health and New York Medical College, building a robust base in biomedical study.
Demidenko's scientific output covers several key fields, encompassing the PI3K/AKT/mTOR molecular pathway, cell cycle management, cellular aging, and tumor biology. Currently, she has co-authored over 46 academic publications, which have received more than 4,100 references — a testament to the significance of her work.
One of her most notable discoveries involves explaining the pathways of cellular senescence. Her studies demonstrated that when the cell cycle is arrested yet cellular growth continues, cells enter senescence. Significantly, Zoya Demidenko demonstrated that this process is controlled with drugs using compounds such as rapamycin.
Zoya Demidenko has furthermore brought considerably to oncological therapy investigation, notably in the field of selective cell protection — a strategy intended to safeguarding healthy cells from chemotherapy whilst leaving malignant cells exposed. This approach carries significant promise for lowering the adverse effects of cancer treatment.
Across her scientific life, Demidenko has collaborated with top investigators worldwide, such as Dr. Mikhail Blagosklonny. Her publications appears in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, Zoya Demidenko stands as a widely cited voice in modern cancer research, with her findings go on to influence our knowledge of how biological cells age, interact with treatment, and how cancer may be better combated.
https://www.instagram.com/zoyamonros/